Table 2 Clinicopathological characteristic of the breast cancer patients and controls
From: Effect of SMAD4 gene polymorphism on breast cancer risk in Bangladeshi women
Characteristics | rs10502913 (n = 70) (%) | Controls (n = 60) (%) |
|---|---|---|
Age, year | Â | Â |
 ≤ 47 | 43 (61.42%) | 41 (68.33%) |
  > 47 | 27 (38.58%) | 19 (36.70%) |
Dwelling | Â | Â |
 Urban | 18 (25.71%) | 43 (71.66%) |
 Rural | 52 (74.29%) | 17(28.34%) |
Menstrual status | Â | Â |
 Pre-menopause | 36 (51.42%) | 28 (46.66%) |
 Post-menopause | 34 (48.58%) | 32 (53.34%) |
Parity | Â | Â |
 0–7 | 62 (88.57%) | 58 (96.66%) |
 > 7 | 8 (11.43%) | 12 (3.34%) |
Contraception | Â | Â |
 Oral pills | 51 (72.85%) | 42 (70%) |
 Others | 8 (11.43%) | 14 (23.33%) |
 None | 11 (15.72%) | 4 (6.66%) |
Family history of cancer (first degree relatives) | Â | Â |
 Yes | 45 (64.28%) | 24 (40%) |
 No | 25 (35.72%) | 36 (60%) |
Stage of cancer | Â | Â |
 IA-IB | 2 (1.28%) | – |
 IIA | 33 (47.14%) | – |
 IIB | 32 (45/71%) | – |
 IIIA-IIIB | 3 (4.28%) | – |
Tumor grade | Â | Â |
 I | 9 (12.85%) | – |
 II | 53(75.71%) | – |
 III | 8 (11.43%) | – |